Allurion Technologies reports Q2 EPS (5c), consensus (24c)

Reports Q2 revenue $11.77M, consensus $10.9M. “After restructuring our business at the end of 2023, the entire Allurion team executed at a high level and posted a second consecutive quarter of sequential revenue growth, record procedure volume, and significant improvements in operating income,” said Dr. Shantanu Gaur, Chief Executive Officer. “With a balance sheet strengthened from our recent public offering, we now believe we have the cash runway to execute through significant milestones and are working toward a plan to achieve profitability by the end of next year.”